UBE2O and diabetes mellitus: This evidence suggests that the development of drugs interfering with UBE2O-AMPK interaction or the pharmacological inhibition of UBE2O activity could represent a powerful strategy for contributing to muscle insulin sensitivity, ameliorating diabetes and metabolic health.